Clinical Trial Update: A Comparative Study of Indobufen and Aspirin in Patients With Coronary Atherosclerosis [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing indobufen and aspirin in patients with coronary atherosclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Atherosclerosis

Drugs mentioned

• Aspirin (Aspirin)
• Indobufen (indobufen)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Coronary Atherosclerosis | Phase 4 | Status: UNKNOWN